Table 1. Comparing baseline values for participants missing/not missing at two-years follow-up using ANOVA.
| Not missing | Missing | P | |||
|---|---|---|---|---|---|
| SD | SD | ||||
| Sex (%Female) | 56 | 56 | 51 | 0.370 | |
| Age (years, mean±SD) | 39.04 | 12.36 | 36.99 | 12.47 | 0.157 |
| Schizophrenia (%) | 88 | 89 | 0.722 | ||
| Employment yes/no (%) | 3 | 3 | 0.929 | ||
| Duration of Illness (years, mean±SD) | 17.62 | 10.92 | 16.91 | 10.87 | 0.589 |
| Supported housing (%) | 09 | 15 | 0.093 | ||
| Antipsychotics yes/no (%) | 96.11 | 92.55 | 0.150 | ||
| Polypharmacia yes/no (%) | 39.82 | 35.11 | 0.409 | ||
| Smoking yes/no (%) | 50.60 | 57.45 | 0.241 | ||
| Weight (kg, mean±SD) | 102.86 | 21.26 | 103.30 | 23.84 | 0.863 |
| BMI (kg/m2, mean±SD) | 34.15 | 5.79 | 34.20 | 6.52 | 0.948 |
| Waist circumference (cm, mean±SD) | 114.55 | 14.60 | 114.74 | 15.61 | 0.911 |
| Systolic blood pressure (mmHg, mean±SD) | 127.78 | 126.85 | 0.577 | ||
| Total cholesterol (mmol/l, mean±SD) | 5.01 | 1.09 | 5.08 | 1.14 | 0.598 |
| HDL (mmol/l, mean±SD) | 1.22 | 0.37 | 1.24 | 0.42 | 0.659 |
| Psychotic symptoms (SAPS, mean±SD) | 2.12 | 1.61 | 2.45 | 1.55 | 0.074 |
| Negative symptoms (SANS, mean±SD) | 2.50 | 1.14 | 2.73 | 1.29 | 0.102 |
| Cognition (BACS, mean±SD) | 228.31 | 48.68 | 213.00 | 49.59 | 0.010 |
| Level of functioning (GAF, mean ±SD) | 44.03 | 44.03 | 42.63 | 7.93 | 0.121 |
SAPS—Scale for the Assessment of Positive Symptoms, SANS—Scale for the Assessment of Negative Symptoms, BACS—Brief Assessment of Cognition in Schizophrenia, GAF—Global Assessment of Functioning, HDL#x2014;high density lipoprotein·